Nuvation Bio Inc. logo

Nuvation Bio Inc.

NYSE:NUVB

Overview | Financials
Company Name Nuvation Bio Inc.
Symbol NUVB
Currency USD
Price 2.6
Market Cap 566,919,600
Dividend Yield 0%
52-week-range 0.95 - 4.16
Industry Biotechnology
Sector Healthcare
CEO Dr. David T. Hung M.D.
Website https://www.nuvationbio.com

An error occurred while fetching data.

About Nuvation Bio Inc.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins

Related Stocks

Invitae Corporation logo

Invitae Corporation

NVTA

0.019 USD

Artivion, Inc. logo

Artivion, Inc.

AORT

20.03 USD

Community Health Systems, Inc. logo

Community Health Systems, Inc.

CYH

2.86 USD

American Well Corporation logo

American Well Corporation

AMWL

0.547 USD

Phreesia, Inc. logo

Phreesia, Inc.

PHR

21.7 USD

Butterfly Network, Inc. logo

Butterfly Network, Inc.

BFLY

0.765 USD

ADC Therapeutics SA logo

ADC Therapeutics SA

ADCT

4.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD